Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon
Overview
Previous study showed that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: August 1, 2018
Detailed Description
In earlier studies investigators claimed that subnormal cortisol response using plastic tubes might result from cosyntropin adherence to the tube and loss of the delivered dosage. It was shown that 21.6-58.6% of ACTH dosage had not been recovered when pushed through 20.3 cm plastic tube, and loss of ACTH may be up to 70% when cosyntropin was delivered through a plastic 30 cm scalp vein set. Moreover, it was previously shown that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.
Interventions
- Diagnostic Test: low-dose cosyntropin stimulation test
- Each subject recruited in the study will undergo low dose cosyntropin stimulation test via intravenous short 2.5 cm plastic tube. 1 μg/ml ACTH aliquot stock solution will be pushed through, followed by 5 ml physiologic saline (0.9%). For each subject, serum and salivary cortisol will be measured just before cosyntropin administration and 30 minutes later.
Arms, Groups and Cohorts
- Experimental: healthy subjects
- 20 healthy subjects will undergo low dose cosyntropin stimulation test. Serum and salivary cortisol will be measured just before cosyntropin administration and 30 minutes later.
Clinical Trial Outcome Measures
Primary Measures
- Blood cortisol
- Time Frame: one day
- Serum cortisol concentrations during intravenous low dose cosyntropin stimulation through short tube.
Secondary Measures
- Salivary free cortisol
- Time Frame: one day
- Salivary free cortisol concentrations during intravenous low dose cosyntropin stimulation through short tube.
Participating in This Clinical Trial
Inclusion Criteria
healthy volunteers Exclusion Criteria:
Clinical suspicion of hypoadrenalism Medical condition or treatment that might alter blood cortisol levels Pregnancy
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 70 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Bnai Zion Medical Center
- Provider of Information About this Clinical Study
- Principal Investigator: leonard.saiegh, MD – Bnai Zion Medical Center
- Overall Official(s)
- Leonard Saiegh, Principal Investigator, Bni-Zion medical center
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.